Overview
Verco is a Polish pharmaceutical company specializing in gynecology, ophthalmology, and skin care. It offers advanced pharmaceutical products, including dietary supplements like Pregna PLUS for pregnant women, MUCOVAGIN for intimate area hydration, and TRIVAGIN, a leading oral gynecological probiotic. The company collaborates closely with medical professionals and bases its products on scientific research and evidence-based medicine.
Financials
Revenue history (in m)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Industry
Bank accounts
Registered as a VAT taxpayer on 2006-11-06. Active
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
MSiG notices
9 notices recorded in the Court and Commercial Gazette (MSiG).
| Publication date | Event | |
|---|---|---|
| Dec 9, 2025 | Financial statement published | |
| Aug 19, 2024 | Financial statement published | |
| Nov 4, 2020 | Commercial Companies Code notice | |
| Oct 7, 2020 | Commercial Companies Code notice | |
| Sep 22, 2020 | Commercial Companies Code notice |
Public aid
4 public aid cases recorded, with a total value of $953,269.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Nov 10, 2021 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | —— | Prezes Banku Gospodarstwa Krajowego | |
| Nov 6, 2020 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | —— | Prezes Banku Gospodarstwa Krajowego | |
| Nov 6, 2020 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | —— | Prezes Banku Gospodarstwa Krajowego |
Tenders
No recorded participation in tenders.
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | BDO register entry | Active |
Authorized Representatives
Manner of representation
In the case of a one-person management board, the member of the management board makes declarations on behalf of the company independently. In the case of a management board consisting of two or more persons, joint action by two members of the management board or by one member of the management board together with a commercial proxy is required to make declarations on behalf of the company.
Supervisory board
Beneficial owners
13 beneficial owners recorded in CRBR.
| Person | Rights | |
|---|---|---|
Agnieszka Bukowińska - Zawadka (62)  | Other natural person. | |
Aleksandra Mania (28) | Other natural person. | |
Anna Mania (25) | Other natural person. | |
Michał Mania (34) | Other natural person. | |
Piotr Mania (14) | Other natural person. | |
Rafał Mania (56) | Other natural person. | |
Jakub Menc (37) | Członek zarządu fram fundacja rodzinna | |
Edyta Puchała (53) | Członek zarządu fram fundacja rodzinna |
Subsidiaries
| Name | Share value | Stake | ||
|---|---|---|---|---|
OFTAsp. z o.o. | 1,350.62 USD | 100% | ||
OFTA Pharmasp. z o.o. | 1,350.62 USD | 100% | ||
Pharma4vetsp. z o.o. | 1,350.62 USD | 100% |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Instytut Biotechnologii Surowic i Szczepionek Biomed - Skrót Firmy Ibss BiomedS.A. | $37,103,878.54 | biomed.pl | ||
| VipharmS.A. | $30,660,173.61 | vipharm.pl |
Change history
| Date | Event | |
|---|---|---|
| 2025-02-07 | PKD change (Removed: 46.19.Z, 46.3, 47.2, 47.91.Z, 63.12.Z; Added: 10.89.A, 46.18.Z, 47.74.Z, 47.75.Z, 63.10) | |
| 2024-10-03 | Share capital change (504,397.00 PLN → 504,397.60 PLN) | |
| 2024-09-12 | Share capital change (636,938.80 PLN → 504,397.00 PLN) | |
| 2022-10-14 | Share capital change (635,288.40 PLN → 636,938.80 PLN) | |
| 2022-07-22 | Share capital change (874,632.20 PLN → 635,288.40 PLN) |
FAQ
Last updated: 2026-08-24